COMBINED BROMOCRIPTINE-LEVODOPA THERAPY EARLY IN PARKINSONS-DISEASE

被引:144
作者
RINNE, UK
机构
关键词
D O I
10.1212/WNL.35.8.1196
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1196 / 1198
页数:3
相关论文
共 26 条
[1]  
[Anonymous], 1982, MOVEMENT DISORD
[2]  
Barbeau A, 1980, PARKINSONS DISEASE C, P229
[3]   BROMOCRIPTINE IN PARKINSONISM [J].
CALNE, DB ;
TEYCHENNE, PF ;
CLAVERIA, LE ;
EASTMAN, R ;
GREENACRE, JK ;
PETRIE, A .
BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5942) :442-444
[4]  
CALNE DB, 1983, LISURIDE OTHER DOPAM, P357
[5]  
Carlsson A, 1983, J Neural Transm Suppl, V19, P153
[6]  
DUVOISIN RC, 1971, MONOAMINES NOYAUX GR, P313
[7]   ROLE OF BROMOCRIPTINE IN THE TREATMENT OF PARKINSONISM [J].
FAHN, S ;
COTE, LJ ;
SNIDER, SR ;
BARRETT, RE ;
ISGREEN, WP .
NEUROLOGY, 1979, 29 (08) :1077-1083
[8]  
GRANERUS AK, 1978, ACTA MED SCAND, V203, P75
[9]   PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].
HOEHN, MM ;
YAHR, MD .
NEUROLOGY, 1967, 17 (05) :427-&
[10]   ANALYSIS OF THE CLINICAL PROBLEMS IN PARKINSONISM AND THE COMPLICATIONS OF LONG-TERM LEVODOPA THERAPY [J].
LESSER, RP ;
FAHN, S ;
SNIDER, SR ;
COTE, LJ ;
ISGREEN, WP ;
BARRETT, RE .
NEUROLOGY, 1979, 29 (09) :1253-1260